Derangement of Liver Enzymes, Hyperglycemia, Anemia, and Associated Factors among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Regimen in Ethiopia: A Prospective Cohort Study

Table 1

Characteristics of study participants.

Variable	Category	Frequency
Age in years	>40	21 (33.3)
Body mass index (in kg/m^2)	≥25	20 (31.75)
Baseline CD4 count	≥200 cells/mm^3	34 (53.97)
WHO stage	I + II	45 (71.43)
	III + IV	18 (28.57)
Marital status	Single	8 (12.7)
	Married	40 (63.5)
	Divorced	11 (17.5)
	Widowed	4 (6.4)
Educational status	Illiterate	5 (7.9)
	Primary	18 (28.6)
	Secondary	28 (44.4)
	Diploma	5 (7.9)
	Degree	7 (11.1)
Occupation	Governmental employee	12 (19)
	Private	34 (54)
	Not employed	17 (27)
Cotrimoxazole px	Yes	42 (66.7)
Isoniazid px	Yes	8 (12.7)
Chemotherapy	Yes	4 (6.3)
NSAIDs	Yes	6 (9.5)
PPI	Yes	9 (14.3)
Antituberculosis drugs	Yes	4 (6.3)
Cancer	Yes	8 (12.7)

CD4: cluster of differentiation; WHO: World Health Organization; Px: prophylaxis; NSAIDs: nonsteroidal anti-inflammatory drugs; PPI: proton pump inhibitor.